Alignment Healthcare, Inc.

Alignment Healthcare, Inc.(ALHC)股票分析

$8.400

+0.122 (+1.45%)收盘时

Loading chart…
最高
8.540
开盘
8.260
成交量加权均价
8.38
成交量
3.59M
市值
1.50B
最低
8.215
成交额
30.08M
企业价值/息税折旧摊销前利润(TTM)
5.73

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.

AI 分析 of Alignment Healthcare, Inc. (ALHC)

卖出

Alignment Healthcare Inc is not a good buy right now. The stock has recently dropped significantly, with a 5-day change of +9.74% but a year-to-date change of -59.05%. The downgrade in star ratings for its Medicare plans has led to a loss of bonus eligibility, which could result in hundreds of millions in revenue loss. Furthermore, the forward P/E ratio is extremely high at 204.08, indicating that the stock may be overvalued given its recent performance and earnings outlook.

估值指标

Alignment Healthcare, Inc.(ALHC)当前预期市盈率为 204.08,5 年平均预期市盈率为 -30.97。

预期市盈率

合理
5 年均值 P/E
-30.97
当前P/E
204.08
高估
395.99
低估
-457.92

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-65.36
当前EV/EBITDA
5.73
高估
244.25
低估
-374.97

预期市销率

低估
5 年均值 P/S
0.89
当前P/S
0.26
高估
1.41
低估
0.37

Alphio AI 对 ALHC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ALHC

$27.62

情景价格

基

基准

基准 · 50%ALHC

$23.77

情景价格

悲

悲观

悲观 · 25%ALHC

$19.40

情景价格

持有 ALHC 的大户

G

General Atlantic Service Company, L.P.

+ 持有ALHC

+4.23%

3个月收益率

O

Osterweis Capital Management, Inc.

+ 持有ALHC

+2.90%

3个月收益率

B

Burkehill Global Management, LP

+ 持有ALHC

-4.81%

3个月收益率

H

Hood River Capital Management LLC

+ 持有ALHC

-12.69%

3个月收益率

事件时间线

2026-10-19 (ET)

11:30:00

Alignment Health Plan Partners with Astrana Health to Expand Care Access

2026-10-09 (ET)

16:30:00

Trump Says U.S. Will Not Strike Iran, Oil Pulls Back

12:00:00

Tech Stock Rebound Boosts Major Averages

09:00:00

U.S. Stock Futures Rise as Oil Prices Ease, Boosting Market Recovery

2026-10-08 (ET)

20:00:00

Nasdaq Composite Falls 1.3% as Tech Stocks Struggle

资讯

ALHC 常见问题 —— 由 Alphio AI 解答

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Alignment Healthcare Inc is not a good buy right now. The stock has recently dropped significantly, with a 5-day change of +9.74% but a year-to-date change of -59.05%. The downgrade in star ratings for its Medicare plans has led to a loss of bonus eligibility, which could result in hundreds of millions in revenue loss. Furthermore, the forward P/E ratio is extremely high at 204.08, indicating that the stock may be overvalued given its recent performance and earnings outlook.

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易